I have written lately about how venture investors who have had long traditions of investing in medical devices are abandoning this sector. Among the reasons given are the increasingly difficult regulatory and reimbursement environments, the lengthy time to liquidity and the anemic IPO market. But having seen a few stories lately about the newest medical […]